Taiwan Wax Co., Ltd. AI Stock Analysis
Taiwan Wax Co., Ltd. (1742) AI Stock Analysis
Taiwan Wax Co., Ltd.
(TPEx:1742)
Taiwan Wax scores in the mid range, held back primarily by a deteriorating core business: revenue has fallen four years running to NT$112 million and the company posted a NT$100 million net loss with deeply negative operating margins. That weakness is partly offset by a fortress balance sheet — debt slashed to NT$96 million, debt-to-equity of just 0.07x, and equity funding about 90% of assets — plus strong positive free cash flow, though that cash appears to stem from asset sales and working capital release rather than sustainable trading. Technicals are the brightest element, with the stock trading above all key moving averages in a well-defined uptrend supported by positive MACD. Valuation provides no cushion: earnings are negative, so the P/E is not meaningful, and there is no dividend. The balance sheet buys time and limits downside, but a stabilization in revenue and a return to operating profitability are needed before the investment case can be viewed more favorably.
Taiwan Wax Co., Ltd. (1742) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.01B
- Dividend Yield
- ―
- Average Volume (3M)
- 182.65K
- Price to Earnings (P/E)
- -39.4
- Beta (1Y)
- 0.02
- Revenue Growth
- -39.62%
- EPS Growth
- 56.82%
- Country
- TW
- Employees
- 80
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Taiwan Wax Co., Ltd. Business Overview & Revenue Model
Company Description
Taiwan Wax Company, Ltd. engages in the global and domestic manufacturing and sale of various refined waxes and their derivative products. The company's offerings include refined paraffin wax, microcrystalline wax, and both light and heavy foots oil...
Taiwan Wax Co., Ltd. Financial Statement Overview
Summary
A sharply split picture. The income statement is the main weakness (score 23): revenue has contracted for four straight years to NT$112 million — down roughly 78% from the 2021 peak — and the company swung to a NT$100 million net loss with an operating margin near -78%, as a shrinking sales base can no longer cover fixed costs. Earnings have been highly erratic, suggesting dependence on non-recurring items. Offsetting this, the balance sheet is a genuine strength (score 75): debt has been cut from NT$2.42 billion to just NT$96 million, debt-to-equity sits at an exceptionally conservative 0.07x, and equity funds about 90% of assets. Cash flow is also solid (score 66) with NT$463 million operating and NT$407 million free cash flow, though this appears driven by asset monetization and working capital release rather than recurring trading profits. Net effect: strong downside protection, but no credible evidence yet of operating recovery.
Income Statement
23NegativeBalance Sheet
75PositiveCash Flow
66Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.12M | 111.70M | 231.19M | 392.00M | 482.01M | 500.46M |
| Gross Profit | 12.71M | 26.90M | 57.23M | 118.05M | 100.72M | 95.67M |
| EBITDA | -43.64M | -65.57M | 134.35M | 92.89M | -86.40M | 413.22M |
| Net Income | -51.91M | -100.50M | 82.72M | 38.30M | -123.64M | 372.96M |
Balance Sheet | ||||||
| Total Assets | 1.45B | 1.43B | 1.85B | 3.77B | 2.62B | 2.41B |
| Cash, Cash Equivalents and Short-Term Investments | 308.26M | 307.59M | 196.06M | 166.64M | 180.73M | 137.71M |
| Total Debt | 127.57M | 96.03M | 404.18M | 2.42B | 1.30B | 890.00M |
| Total Liabilities | 174.60M | 143.45M | 458.58M | 2.47B | 1.36B | 1.02B |
| Stockholders Equity | 1.27B | 1.29B | 1.39B | 1.30B | 1.26B | 1.39B |
Cash Flow | ||||||
| Free Cash Flow | -65.90M | 406.88M | 266.52M | 105.11M | -192.13M | -748.48M |
| Operating Cash Flow | -37.58M | 463.39M | 369.01M | 355.54M | -139.04M | -522.63M |
| Investing Cash Flow | 12.27M | -4.31M | 1.63B | -1.49B | -223.03M | -108.60M |
| Financing Cash Flow | 20.07M | -308.05M | -2.02B | 1.11B | 396.75M | 390.61M |
Taiwan Wax Co., Ltd. Peers Comparison
Overall Rating
TW:689970Outperform
TW:174256Neutral
TW:173553Neutral
TW:132351Neutral
TW:132541Neutral
TW:893539Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | TWD 2.05B | 12.78 | ― | 5.80% | 1.56% | 9.82% | |
| 56Neutral | TWD 1.99B | -39.37 | ― | ― | -39.62% | 56.82% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | TWD 1.90B | 16.32 | ― | 3.40% | -5.97% | 162.82% | |
| 51Neutral | TWD 1.99B | 17.24 | ― | 4.11% | -3.86% | -37.34% | |
| 41Neutral | TWD 2.16B | -62.78 | ― | 1.19% | -21.19% | 47.07% | |
| 39Underperform | TWD 1.96B | -30.27 | ― | ― | -13.84% | 12.29% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1742 | Taiwan Wax Co., Ltd. | 21.85 | 7.85 | 56.07% | |
| TW:1323 | Yonyu Plastics Co., Ltd | 21.90 | 3.19 | 17.05% | |
| TW:1325 | Universal Incorporation | 25.30 | -5.35 | -17.46% | |
| TW:1735 | Evermore Chemical Industry Co., Ltd. | 19.10 | 4.81 | 33.69% | |
| TW:6899 | Apex Material Technology Corp. | 48.30 | -2.63 | -5.16% | |
| TW:8935 | Pontex Polyblend Co. Ltd. | 17.30 | -1.65 | -8.71% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
